# Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer

> **NCT06850545** · — · RECRUITING · sponsor: **Kuopio University Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Metastatic Prostate Adenocarcinoma
- PSMA PET-Positive Castration-Resistant Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06850545
- **Lead sponsor:** Kuopio University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-10
- **Primary completion:** 2030-12-31
- **Final completion:** 2035-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06850545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06850545, "Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06850545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*